Good practice for introducing radiopharmaceuticals for clinical use.

"The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases --- information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivités auteurs: Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear (sponsoring body.), Asia Oceania Federation of Nuclear Medicine & Biology (sponsoring body.), European Association of Nuclear Medicine (sponsoring body.), Society of Nuclear Medicine and Molecular Imaging (sponsoring body.), World Federation of Nuclear Medicine and Biology (sponsoring body.)
Format: Électronique eBook
Langue:Inglés
Publié: Vienna : International Atomic Energy Agency, 2016.
Collection:IAEA-TECDOC ; 1782.
Sujets:
Radiopharmaceuticals.
Radioisotopes in medical diagnosis.
Nuclear medicine.
Radiopharmaceuticals
Radioisotopes > therapeutic use
Nuclear Medicine
Radiopharmaceutiques.
Isotopes radioactifs dans le diagnostic.
Médecine nucléaire.
Nuclear medicine
Radioisotopes in medical diagnosis
Accès en ligne:Texto completo

Internet

Texto completo

Items no disponibles

Informations d'exemplaires de

Documents similaires